1. Homepage
  2. Equities
  3. Canada
  4. Bourse de Toronto
  5. Genix Pharmaceuticals Corporation
  6. News
  7. Summary
    GENX   CA37232A1093

GENIX PHARMACEUTICALS CORPORATION

(GENX)
Delayed Bourse de Toronto  -  05/25 11:06:54 am EDT
0.1200 CAD    0.00%
04/27GENIX PHARMACEUTICALS : - Form of Proxy
PU
04/27GENIX PHARMACEUTICALS : - Notice and Information Circular
PU
03/25Genix Pharmaceuticals Corporation Reports Earnings Results for the First Quarter Ended January 31, 2022
CI
SummaryQuotesChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Genix Pharmaceuticals Corporation Reports Earnings Results for the Third Quarter Ended July 31, 2021

09/22/2021 EDT

Genix Pharmaceuticals Corporation announced earnings results for the third quarter ended July 31, 2021. For the third quarter, the company announced net loss was CAD 488,451 compared to CAD 71,270 a year ago. Basic loss per share from continuing operations was CAD 0.01. For the nine months, net loss was CAD 1.283 million compared to CAD 155,594 a year ago. Basic loss per share from continuing operations was CAD 0.02.


© S&P Capital IQ 2021
All news about GENIX PHARMACEUTICALS CORPORATION
04/27GENIX PHARMACEUTICALS : - Form of Proxy
PU
04/27GENIX PHARMACEUTICALS : - Notice and Information Circular
PU
03/25Genix Pharmaceuticals Corporation Reports Earnings Results for the First Quarter Ended ..
CI
02/28Genix Pharmaceuticals Corporation Reports Earnings Results for the Full Year Ended Octo..
CI
2021Genix Pharmaceuticals Corporation Reports Earnings Results for the Third Quarter Ended ..
CI
2021GENIX PHARMACEUTICALS CORP : oration Receives Natural Product Number for Rechlor from Heal..
AQ
2021Genix Pharmaceuticals Corp. Receives Approval for Drug Establishment License
NE
2021Genix Pharmaceuticals Corporation Reports Earnings Results for the Second Quarter Ended..
CI
2021GENIX PHARMACEUTICALS : Starts Trading on OTCQB Venture Market Exchange
MT
2021Genix Pharmaceuticals Corp. Lists on the OTCQB Venture Market Exchange
NE
More news
Financials
Sales 2021 - - -
Net income 2021 -1,65 M -1,29 M -1,29 M
Net cash 2021 0,09 M 0,07 M 0,07 M
P/E ratio 2021 -5,38x
Yield 2021 -
Capitalization 7,11 M 5,56 M 5,56 M
EV / Sales 2020 -
EV / Sales 2021 -
Nbr of Employees -
Free-Float 55,5%
Chart GENIX PHARMACEUTICALS CORPORATION
Duration : Period :
Genix Pharmaceuticals Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
Sina Salehi Pirooz Chief Executive Officer & Director
Mahmoud S. Aziz President & Director
Danny W. K. Lee Chief Financial Officer
Darryl J. Yea Chairman
Kevin James Bottomley Independent Director
Sector and Competitors